Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abingdon, Stason in Services Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Abingdon, Stason in Services Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abingdon Life Sciences has entered into an agreement with Stason Pharmaceuticals to provide clinical and regulatory support for Stason’s drug development programs. As part of the agreement, Abingdon will provide clinical and regulatory services for Stason’s pipeline of potential drug candidates and devices in the areas of cancer and inflammation.  

“We are extremely happy to have formalized our relationship with Stason, and believe that this represents a synergistic opportunity for both our companies to leverage our respective core competencies in drug development and manufacturing,” said Richard Lebovitz, Abingdon’s chief executive officer.

Harry Fan, chief executive officer of Stason, added, “Stason is pleased to have agreed to this strategic partnership with Abingdon. It is a mutually beneficial relationship bringing expertise in many areas to our clients, both here in the US and in our overseas markets.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics